Syrjala Karen L, Schoemans Hélène, Yi Jean C, Langer Shelby L, Mukherjee Ahona, Onstad Lynn, Lee Stephanie J
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Psychiatry and Behavioral Science and Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Department of Hematology, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
Transplant Cell Ther. 2021 Jan;27(1):80.e1-80.e12. doi: 10.1016/j.bbmt.2020.09.027. Epub 2020 Sep 29.
This investigation characterized sexual activity and sexual function in hematopoietic cell transplantation (HCT) survivors, compared them with norms, and examined factors associated with sexual dysfunction, with the goal of identifying targets for intervention to improve sexual health. Surviving adults from a large transplantation center were asked to complete an annual survey with a core of health questions and a module on sexual activity and function. Participants completed the Sexual Function Questionnaire, Cancer and Treatment Distress form, and Revised Dyadic Adjustment Scale. Clinical data were collected from the transplantation medical database. Multivariate logistic regressions identified factors associated with sexual activity and function. Participating survivors (n = 1742) were a mean of 11.9 years (range, .4 to 43.1 years) after HCT, mean age 57.6 years, and 53% male. Women were more likely than men to report being sexually inactive in the past year (39% versus 27%) and, among those sexually active, to report low sexual function (64% versus 32%). Male and female survivors reported lower rates of sexual activity and function than comparison norms (all P < .01). In regressions, factors associated with being sexually inactive included older age, having <4 years of college education, low performance status, and not being in a committed relationship. Additional factors for men included receipt of nonmyeloablative conditioning and not being employed or in school. Low sexual functioning for men and women was associated with low performance status, and, for women, a committed relationship of lower quality, while for men the association was with older age. Sexual dysfunction is common in both men and women after HCT, regardless of time since treatment. Survivors need routine evaluation and access to multimodal interventions.
本研究对造血细胞移植(HCT)幸存者的性活动和性功能进行了特征描述,将他们与正常标准进行比较,并研究了与性功能障碍相关的因素,目的是确定改善性健康的干预目标。来自一个大型移植中心的成年幸存者被要求完成一项年度调查,其中包括一系列核心健康问题以及一个关于性活动和性功能的模块。参与者完成了性功能问卷、癌症与治疗困扰量表以及修订后的二元调适量表。临床数据从移植医疗数据库中收集。多变量逻辑回归分析确定了与性活动和性功能相关的因素。参与研究的幸存者(n = 1742)在HCT后平均为11.9年(范围为0.4至43.1年),平均年龄57.6岁,男性占53%。在过去一年中,女性比男性更有可能报告无性活动(39%对27%),并且在有性活动的人群中,女性报告性功能低下的比例更高(64%对32%)。男性和女性幸存者报告的性活动和性功能发生率低于对照标准(所有P < 0.01)。在回归分析中,与无性活动相关的因素包括年龄较大、大学教育年限不足4年、身体状况不佳以及没有稳定的恋爱关系。男性的其他相关因素包括接受非清髓性预处理以及未就业或未上学。男性和女性的性功能低下与身体状况不佳有关,对于女性而言,还与质量较低的稳定恋爱关系有关,而对于男性来说,则与年龄较大有关。无论治疗后时间长短,HCT后男性和女性的性功能障碍都很常见。幸存者需要进行常规评估并获得多模式干预。